Abstract: An RF catheter for treating hypertrophic cardiomyopathy includes: a body part constituting a catheter body made of a flexible and soft material; and an intraseptal insertion part provided at a distal part of the body part and having one or more electrodes, a tapered tip gradually becoming thinner toward an end thereof, and a guidewire lumen therein, into which a guidewire is inserted, so that during hypertrophic cardiomyopathy treatment, the intraseptal insertion part is inserted into the interventricular septum along the guidewire. A method of treating hypertrophic cardiomyopathy by using an RF ablation catheter includes: i) positioning the guidewire to a hypertrophied septum through a coronary sinus and a septal vein; ii) transferring the RF ablation catheter to the hypertrophied septum; and iii) performing RF ablation by applying RF energy to the electrodes provided at an end part of the RF ablation catheter by using an RF generator.

Abstract: A device for reducing mitral valve regurgitation comprises a first protective tube and a second protective tube. Proximal portions of the two protective tubes are being attached side-by-side along at least a portion of the length of the two protective tubes to define a stem portion. Distal portions of the two protective tubes are being separated thereafter to define a hinge portion. The MLC device has a stopper being attached on the distal end of the second protective tube to configure to prevent further advancement of the second protective tube into heart muscle. The first protective tube has at least one anchor disposed between the hinge portion and the distal end of the first protective tube. The anchor configured to lodge into a coronary sinus and maintain the tissue protective device in place.

Abstract: An RF catheter for treating hypertrophic cardiomyopathy includes: a body part constituting a catheter body made of a flexible and soft material; and an intraseptal insertion part provided at a distal part of the body part and having one or more electrodes, a tapered tip gradually becoming thinner toward an end thereof, and a guidewire lumen therein, into which a guidewire is inserted, so that during hypertrophic cardiomyopathy treatment, the intraseptal insertion part is inserted into the interventricular septum along the guidewire. A method of treating hypertrophic cardiomyopathy by using an RF ablation catheter includes: i) positioning the guidewire to a hypertrophied septum through a coronary sinus and a septal vein; ii) transferring the RF ablation catheter to the hypertrophied septum; and iii) performing RF ablation by applying RF energy to the electrodes provided at an end part of the RF ablation catheter by using an RF generator.

Abstract: The present disclosure relates to a RF ablation catheter for septal reduction therapy having a cooling effect, and more particularly, to a RF ablation catheter for septal reduction therapy that is for performing RF ablation, in which RF energy is applied to an interventricular septum, for septal reduction therapy such as therapy for hypertrophic cardiomyopathy, which is a disease in which an interventricular septum of the left ventricle of the heart of the animal or human body thickens, therapy that requires reduction of an interventricular septum, or therapy for ventricular tachycardia. Also, the present disclosure relates to a RF ablation catheter for septal reduction therapy having a cooling effect that is for preventing carbonization of a tissue of the body (interventricular septum) around an electrode.

Abstract: A device for performing tricuspid regurgitation operation is proposed. The device for performing tricuspid regurgitation operation is easily inserted through the inferior vena cava, the tricuspid valve, and the pulmonary artery in sequence in order to treat tricuspid regurgitation (TR) which is a disease where blood from the right ventricle flows back into the right atrium through an empty space (i.e., orifice) formed by incomplete closing of the tricuspid valve (TV) which is positioned between the right atrium and the right ventricle of the heart. The device includes: a fixing member for pulmonary artery installed in the pulmonary artery; a fixing member for inferior vena cava installed in the inferior vena cava; a connecting tube connecting the fixing member for the pulmonary artery and the fixing member for the inferior vena cava to each other; and a blocking part passing obliquely through the tricuspid valve.

Abstract: The present disclosure relates to a tricuspid regurgitation surgical instrument having a position-fixing tube that is for temporarily treating tricuspid regurgitation, and more particularly, to a tricuspid regurgitation surgical instrument having a position-fixing tube that is a surgical instrument temporarily inserted into an orifice of the tricuspid valve to check whether right-sided heart failure has occurred, which may occur when tricuspid regurgitation is treated using a permanent method in a patient with tricuspid regurgitation, and that has a position-fixing tube inserted into a coronary sinus so that a blocking part configured to block the orifice of the tricuspid valve penetrates a plane similar to a plane of leaflets of the tricuspid valve and has a penetration angle which allows the blocking part to efficiently block the orifice of the tricuspid valve.

Abstract: A transcatheter device for treating the tricuspid valve regurgitation. The transcatheter device comprises a main shaft, a proximal portion, a distal tail, and a spacer body mounted on the main shaft and located between the proximal portion and the distal tail. This transcatheter device could be used for treating tricuspid valve regurgitation in a patient's heart. All or part of the transcatheter device is supported by the main shaft. The spacer body is mounted on the shaft, which travels through the spacer body. Also disclosed are a coaptation assembly that comprises the transcatheter device, and a method of treating tricuspid valve regurgitation using the transcatheter device.

Abstract: A mitral cerclage annuloplasty apparatus comprising of a catheter with a blocking member and a capturing member. The blocking member is in the shape of a pigtail or a balloon, and is configured on the distal portion of the catheter preventing the catheter from traversing through an unsafe zone thereby enabling the catheter to pass through the safe zone. This prevents damage to critical cardiac tissues. The capturing member is adapted for pulling out a RVOT cerclage wire into the IVC, and comprises of an expandable and collapsible mesh so that the RVOT cerclage wire is captured and directed into the IVC through the safe zone. Thus the RVOT cerclage wire is passed through the RV without damaging the heart tissue forming a complete circle around the mitral valvular annulus.

Abstract: The present disclosure relates to a RF ablation catheter for septal reduction therapy having a cooling effect, and more particularly, to a RF ablation catheter for septal reduction therapy that is for performing RF ablation, in which RF energy is applied to an interventricular septum, for septal reduction therapy such as therapy for hypertrophic cardiomyopathy, which is a disease in which an interventricular septum of the left ventricle of the heart of the animal or human body thickens, therapy that requires reduction of an interventricular septum, or therapy for ventricular tachycardia. Also, the present disclosure relates to a RF ablation catheter for septal reduction therapy having a cooling effect that is for preventing carbonization of a tissue of the body (interventricular septum) around an electrode.

Abstract: A transcatheter device for treating the tricuspid valve regurgitation. The transcatheter device comprises a main shaft, a proximal portion, a distal tail, and a spacer body mounted on the main shaft and located between the proximal portion and the distal tail. This transcatheter device could be used for treating tricuspid valve regurgitation in a patient's heart. All or part of the transcatheter device is supported by the main shaft. The spacer body is mounted on the shaft, which travels through the spacer body. Also disclosed are a coaptation assembly that comprises the transcatheter device, and a method of treating tricuspid valve regurgitation using the transcatheter device.

Abstract: The invention concerns a radiofrequency (RF) ablation catheter (100) comprising: a flexible shaft (110) extending between a distal end and a proximal end: an inflatable balloon (120) mounted on the shaft (110); and an RF conductor element (115), wherein a portion of the flexible shaft (110) is distal to the inflatable balloon (120) and is defined as a distal segment (119) of the shaft (110), and wherein the RF conductor element (115) is located on the distal segment (119) and is adapted to electrically contact and to deliver RF energy to a liquid metal (150).

Abstract: A device for performing tricuspid regurgitation operation is proposed. The device for performing tricuspid regurgitation operation is easily inserted through the inferior vena cava, the tricuspid valve, and the pulmonary artery in sequence in order to treat tricuspid regurgitation (TR) which is a disease where blood from the right ventricle flows back into the right atrium through an empty space (i.e., orifice) formed by incomplete closing of the tricuspid valve (TV) which is positioned between the right atrium and the right ventricle of the heart. The device includes: a fixing member for pulmonary artery installed in the pulmonary artery; a fixing member for inferior vena cava installed in the inferior vena cava; a connecting tube connecting the fixing member for the pulmonary artery and the fixing member for the inferior vena cava to each other; and a blocking part passing obliquely through the tricuspid valve.

Abstract: The present disclosure provides a method for treatment of atrial fibrillation of the heart, the method including: inserting a guidewire from the superior vena cava or inferior vena cava into the vein of Marshall via a coronary sinus; placing a RF ablation catheter, which has an ablation electrode formed on a distal part, in the vein of Marshall according to guidance of the guidewire; and performing RF ablation around the vein of Marshall after connecting the RF ablation catheter to a RF generator.

Abstract: A transcatheter device for treating the tricuspid valve regurgitation. The transcatheter device comprises a main shaft, a proximal portion, a distal tail, and a spacer body mounted on the main shaft and located between the proximal portion and the distal tail. This transcatheter device could be used for treating tricuspid valve regurgitation in a patient's heart. All or part of the transcatheter device is supported by the main shaft. The spacer body is mounted on the shaft, which travels through the spacer body. Also disclosed are a coaptation assembly that comprises the transcatheter device, and a method of treating tricuspid valve regurgitation using the transcatheter device.

Abstract: A pacemaker lead for cerclage pacing includes a lead fixing part including a fixing tip whose diameter becomes gradually smaller toward an end of a distal part thereof, a plurality of bipolar electrodes that come into close contact with heart muscle, in an outer circumference of the lead fixing part, and a guide wire insertion through hole through which a guide wire can be inserted thereinto, a lead body part configured to be extended to the lead fixing part, having a stylet insertion through hole formed therein, and a body fixing part formed in a bent shape so as to be fixed to an inner wall of the coronary sinus, and a stylet inserted into the stylet insertion through hole, enabling the pacemaker lead for cerclage pacing to be easily moved within the body of the patient.

Abstract: A transcatheter device for treating the mitral valve regurgitation. This device could be a mitral valve cerclage assembly comprising a cerclage tube and a cerclage rope passing through the cerclage tube. The cerclage tube comprises (a) a stem comprising a hinge and a pre-hinge segment having a curve shape, wherein the pre-hinge segment spans proximally from the hinge; (b) a coronary sinus arm; (c) a tricuspid valve arm; and (d) a stopper located at a distal end of the tricuspid valve arm. In the assembly, the cerclage rope passes through the stem, out of the coronary sinus arm, through the tricuspid valve arm to form a loop, and back through the stem. Also disclosed are a heart cerclage kit for treating mitral valve regurgitation, and a method of treating mitral valve regurgitation in a patient's heart.

Abstract: This disclosure is related to methods, devices, assemblies, and system for transbronchial ablation of a lung tumor. Aspects of the disclosure are included as follows. A radiofrequency (RF) ablation catheter which is configured to heat a passageway filled with a liquid metal, the ablation catheter comprises a flexible shaft having a proximal end and a distal end, the flexible shaft having a fluid channel configured to instill the liquid metal into the passageway. The ablation catheter further comprises an inflatable balloon mounted on the flexible shaft wherein a portion of the flexible shaft that is distal to the balloon is defined as a distal segment of the flexible shaft, the balloon configured to obstruct the passageway. The ablation catheter comprises an RF conductor located on the distal segment configured for connecting RF energy to the liquid metal thereby heating the passageway.

Abstract: A pacemaker lead for cerclage pacing includes a lead fixing part including a fixing tip whose diameter becomes gradually smaller toward an end of a distal part thereof, a plurality of bipolar electrodes that come into close contact with heart muscle, in an outer circumference of the lead fixing part, and a guide wire insertion through hole through which a guide wire can be inserted thereinto, a lead body part configured to be extended to the lead fixing part, having a stylet insertion through hole formed therein, and a body fixing part formed in a bent shape so as to be fixed to an inner wall of the coronary sinus, and a stylet inserted into the stylet insertion through hole, enabling the pacemaker lead for cerclage pacing to be easily moved within the body of the patient.

Abstract: A method of creating a transvenous access pathway into an interventricular septum of a patient's heart. This access pathway could be used for cardiac procedures such as cardiac pacing, RF (radiofrequency) ablation, or mitral valve cerclage procedures. The method uses a catheter device that is steerable at its distal end. After passing through the coronary sinus and into coronary vein (e.g. great cardiac vein), a puncture tool is advanced through the catheter device and made to puncture through the vein wall. To facilitate this, the distal end of the catheter device may be bent at an angle towards the vein wall. The puncture tool is pushed to bore through the myocardium towards the interventricular septum. This creates an entry passageway from the coronary vein, through the myocardium, and into the interventricular septum. This entry passageway could be used for insertion of an electrode lead or a mitral loop cerclage wire.